Enanta’s Zelicapavir Shows Positive Phase 2b Results for RSV in High-Risk Adults
Enanta Pharmaceuticals Inc. (NASDAQ:ENTA) is one of the best hot stocks to invest in.
Posts Tagged ‘NASDAQ:ENTA’
12 Best Hot Stocks to Invest In
On September 24, Ryan Detrick, Carson Group chief market strategist, joined CNBC's 'Power Lunch' to discuss why he still expects a strong end-of-year rally.
11 Best Breakout Stocks to Buy According to Analysts
In this article, we discuss 11 Best Breakout Stocks to Buy According to Analysts.
7 Best Nano Cap Stocks To Invest In
In this article, we will look at the 7 Best Nano Cap Stocks To Invest In.
Top 10 Holdings of Caligan Partners
In this piece, we will take a look at the Top 10 holdings of Caligan Partners. Founded in 2017, Caligan Partners is one of the most significant specialty hedge funds.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript May 6, 2024 Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript February 7, 2024 Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q4 2023 Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q4 2023 Earnings Call Transcript November 20, 2023 Enanta Pharmaceuticals, Inc. beats earnings expectations.
Top 5 Stock Picks of Farallon Capital
In this article, we discuss the top 5 stock picks of Farallon Capital.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q3 2023 Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q3 2023 Earnings Call Transcript August 7, 2023 Enanta Pharmaceuticals, Inc. misses on earnings expectations.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2023 Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2023 Earnings Call Transcript May 8, 2023 Enanta Pharmaceuticals, Inc. beats earnings expectations.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2023 Earnings Call Transcript
Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q4 2022 Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q4 2022 Earnings Call Transcript November 21, 2022 Enanta Pharmaceuticals, Inc. beats earnings expectations.
10 Best Pharmaceutical Stocks to Buy According to Steven Boyd’s Armistice Capital
In this article, we will take a look at some of the notable pharma stocks to buy according to Steven Boyd's Armistice Capital.
Enanta Pharmaceuticals Inc (ENTA): Hedge Funds In Wait-and-See Mode
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Here is What Hedge Funds Think About Enanta Pharmaceuticals Inc (ENTA)
Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research.
Hedge Funds Are Crazy About Enanta Pharmaceuticals Inc (ENTA)
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable...
These Are Apex Capital Management’s Top Biotech Stock Picks
Founded in 1987, Apex Capital Management invests mainly in companies that have market caps of up to $10 billion and is currently overseeing $6.5 billion in assets under management...
Akorn, Inc. (AKRX), United Therapeutics Corporation (UTHR) Among Consonance Capital’s Winning Bets in Healthcare
The $5.50 billion pharmaceutical company Akorn, Inc. (NASDAQ:AKRX) was one of the top gainers on Wednesday, closing the session with an almost 10% gain.
Apple Inc. (AAPL), BioDelivery Sciences International Inc. (BDSI) Among Thomas Bailard’s Top Q2 Top Picks
Thomas Bailard is the co-founder and current manager of Bailard Inc. Located in California, Bailard uses quantitative and fundamental analyses to choose its investments.
Consonance Capital Management is Fond of Healthcare Stocks
Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD.
Ra Capital Management Reveals New Stake in Enanta Pharmaceuticals Inc (ENTA)
Peter Kolchinsky's Ra Capital Management disclosed a new position in Enanta Pharmaceuticals Inc (NASDAQ:ENTA).
Hedge Fund Resource Center
